Ho-Chou Tu

2.7k total citations · 2 hit papers
18 papers, 2.0k citations indexed

About

Ho-Chou Tu is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ho-Chou Tu has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ho-Chou Tu's work include Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (4 papers) and Mitochondrial Function and Pathology (2 papers). Ho-Chou Tu is often cited by papers focused on Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (4 papers) and Mitochondrial Function and Pathology (2 papers). Ho-Chou Tu collaborates with scholars based in United States, Netherlands and Sweden. Ho-Chou Tu's co-authors include Emily H. Cheng, James J. Hsieh, Hyungjin Kim, John Jeffers, Gerard P. Zambetti, Decheng Ren, Osamu Takeuchi, Evripidis Gavathiotis, Gregory H. Bird and Samuel G. Katz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ho-Chou Tu

18 papers receiving 2.0k citations

Hit Papers

Hierarchical regulation of mitochondrion-dependent apopto... 2006 2026 2012 2019 2006 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho-Chou Tu United States 11 1.6k 343 321 277 210 18 2.0k
Christine Bonzon United States 12 1.7k 1.0× 459 1.3× 450 1.4× 248 0.9× 181 0.9× 34 2.3k
Mari Nishino United States 8 1.3k 0.8× 309 0.9× 228 0.7× 285 1.0× 316 1.5× 12 1.7k
Jarrod J. Sandow Australia 25 1.3k 0.8× 276 0.8× 502 1.6× 284 1.0× 224 1.1× 52 1.8k
Margaret A. Park United States 28 1.4k 0.8× 574 1.7× 269 0.8× 513 1.9× 311 1.5× 55 2.1k
Chun Hei Antonio Cheung Taiwan 25 1.2k 0.8× 497 1.4× 203 0.6× 234 0.8× 298 1.4× 60 1.8k
Shuang Shang China 15 1.0k 0.6× 357 1.0× 205 0.6× 194 0.7× 285 1.4× 23 1.6k
Zhenbo Zhang China 26 1.1k 0.6× 343 1.0× 443 1.4× 197 0.7× 129 0.6× 84 2.0k
X. Wei Meng United States 21 901 0.5× 335 1.0× 246 0.8× 166 0.6× 134 0.6× 31 1.4k
Futoshi Suizu Japan 20 1.4k 0.9× 511 1.5× 617 1.9× 287 1.0× 280 1.3× 44 2.0k
Ulrik Lademann Denmark 17 1.1k 0.7× 319 0.9× 259 0.8× 315 1.1× 326 1.6× 27 1.7k

Countries citing papers authored by Ho-Chou Tu

Since Specialization
Citations

This map shows the geographic impact of Ho-Chou Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho-Chou Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho-Chou Tu more than expected).

Fields of papers citing papers by Ho-Chou Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho-Chou Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho-Chou Tu. The network helps show where Ho-Chou Tu may publish in the future.

Co-authorship network of co-authors of Ho-Chou Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Ho-Chou Tu. A scholar is included among the top collaborators of Ho-Chou Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho-Chou Tu. Ho-Chou Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ward, Lucas D., et al.. (2024). AAV-mediated hepatic expression of SLC30A10 and the Thr95Ile variant attenuates manganese excess and other phenotypes in Slc30a10-deficient mice. Journal of Biological Chemistry. 300(3). 105732–105732. 3 indexed citations
2.
Ye, Dien, Richard van Veghel, Ingrid M. Garrelds, et al.. (2024). Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension. 81(7). 1491–1499. 10 indexed citations
3.
Noetzli, Leila, Anna Borodovsky, Justin Darcy, et al.. (2023). 830-P: Preclinical Development of ALN-KHK, an Investigational RNAi Therapeutic for Type 2 Diabetes Mellitus. Diabetes. 72(Supplement_1). 1 indexed citations
4.
Ye, Dien, et al.. (2023). Targeting Angiotensinogen With N -Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure. Arteriosclerosis Thrombosis and Vascular Biology. 43(12). 2256–2264. 9 indexed citations
5.
Ward, Lucas D., Margaret M. Parker, Aimée M. Deaton, et al.. (2021). Rare coding variants in DNA damage repair genes associated with timing of natural menopause. Human Genetics and Genomics Advances. 3(2). 100079–100079. 11 indexed citations
6.
Park, Sehyung, Robert N. Helsley, Leila Noetzli, et al.. (2021). A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes. STAR Protocols. 2(3). 100731–100731. 5 indexed citations
7.
Weng, Jui–Hsia, Peter D. Koch, Harding H. Luan, et al.. (2021). Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nature Metabolism. 3(4). 513–522. 65 indexed citations
8.
Ha, Jeung‐Hoi, Ho-Chou Tu, Stephan Wilkens, & Stewart N. Loh. (2021). Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2). Journal of Biological Chemistry. 296. 100446–100446. 12 indexed citations
9.
Weng, Jui–Hsia, Peter D. Koch, Harding H. Luan, et al.. (2021). Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nature Metabolism. 3(5). 728–728. 1 indexed citations
10.
Tsiolaki, Paraskevi L., et al.. (2019). Delving into the amyloidogenic core of human leukocyte chemotactic factor 2. Journal of Structural Biology. 207(3). 260–269. 6 indexed citations
11.
Kim, Peter G., Matthew C. Canver, Catherine Rhee, et al.. (2016). Interferon-α signaling promotes embryonic HSC maturation. Blood. 128(2). 204–216. 36 indexed citations
12.
Chen, David Y., Han Liu, Shugaku Takeda, et al.. (2010). Taspase1 Functions as a Non-Oncogene Addiction Protease that Coordinates Cancer Cell Proliferation and Apoptosis. Cancer Research. 70(13). 5358–5367. 29 indexed citations
13.
Kim, Hyungjin, Ho-Chou Tu, Decheng Ren, et al.. (2009). Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis. Molecular Cell. 36(3). 487–499. 477 indexed citations
14.
Tu, Ho-Chou, Decheng Ren, David Y. Chen, et al.. (2009). The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. Proceedings of the National Academy of Sciences. 106(4). 1093–1098. 95 indexed citations
15.
Ren, Decheng, Hyungjin Kim, Ho-Chou Tu, et al.. (2009). The VDAC2-BAK Rheostat Controls Thymocyte Survival. Science Signaling. 2(85). 41 indexed citations
16.
Gavathiotis, Evripidis, Motoshi Suzuki, Marguerite L. Davis, et al.. (2008). BAX activation is initiated at a novel interaction site. Nature. 455(7216). 1076–1081. 542 indexed citations breakdown →
17.
Gavathiotis, Evripidis, Motoshi Suzuki, Marguerite L. Davis, et al.. (2008). Structural Analysis of a BAX-BIM SAHB Complex Reveals a Novel BH3 Interaction Site on BAX for Therapeutic Activation of Apoptosis. Blood. 112(11). 300–300. 1 indexed citations
18.
Kim, Hyungjin, Ho-Chou Tu, John Jeffers, et al.. (2006). Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nature Cell Biology. 8(12). 1348–1358. 689 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026